# FOXD4

## Overview
FOXD4 is a gene that encodes the forkhead box D4 protein, a member of the forkhead family of transcription factors. This family is characterized by a conserved forkhead or winged-helix DNA-binding domain, which is crucial for the protein's role in regulating gene expression. The FOXD4 gene is located on chromosome 9p24 and is intronless, with significant expression in the heart, skeletal muscle, and brain tissues, both in adults and during fetal development (Minoretti2007A). The forkhead box D4 protein functions as a transcriptional regulator, influencing processes such as cell differentiation, proliferation, and embryogenesis. It acts as both a transcriptional activator and repressor, depending on the context, and is involved in critical developmental pathways, particularly in neural development and tissue patterning (Jackson2010Update; Tokuhiro2017Differential). The evolutionary conservation of the forkhead domain across species highlights its essential role in maintaining fundamental biological functions (Jackson2010Update).

## Structure
The FOXD4 protein is a member of the forkhead family of transcription factors, characterized by a conserved forkhead or winged-helix DNA-binding domain. This domain is approximately 100 amino acids long and forms a helix-turn-helix structure, which is crucial for its function as a transcription factor (Jackson2010Update). The FOXD4 protein in humans is intronless and located at 9p24, with high expression in the heart, skeletal muscle, and brain (Minoretti2007A).

The protein structure includes an N-terminal DNA-binding acidic blob domain, a winged helix domain, and a C-terminal Engrailed homology region-1 (Eh1) domain (Tokuhiro2017Differential; McMahon2022Loss). These domains contribute to its dual functionality as both a transcriptional activator and repressor, influencing gene expression and cellular fate (Tokuhiro2017Differential).

Mutations in the FOXD4 gene, such as the W148R mutation, can affect the conserved tryptophan residue in the forkhead domain, potentially altering DNA binding and transcriptional activity, which has been linked to various diseases (Minoretti2007A). The protein may also undergo post-translational modifications, although specific details are not provided in the available context.

## Function
FOXD4 is a transcription factor belonging to the forkhead/winged helix box (FOX) gene family, which plays a crucial role in regulating gene expression during ontogenesis. The FOXD4 gene is intronless and located on chromosome 9p24. It is highly expressed in the heart, skeletal muscle, and both adult and fetal brain tissues, indicating its significant role in these areas (Minoretti2007A). The protein encoded by FOXD4 contains a highly conserved DNA-binding domain known as the forkhead domain, essential for its function as a transcription factor. This domain allows FOXD4 to bind to specific DNA sequences, thereby influencing the transcription of target genes involved in cell differentiation, proliferation, and embryogenesis (Jackson2010Update; Minoretti2007A).

In healthy human cells, FOXD4 is active in the nucleus, where it influences processes such as neural development and tissue patterning. Although specific functions of FOXD4 in healthy human cells are not detailed, its expression in cerebral and cardiac tissues suggests a role in the development and function of these organs (Jackson2010Update). The evolutionary conservation of the forkhead domain across species underscores its importance in maintaining essential biological functions (Jackson2010Update).

## Clinical Significance
Mutations and altered expression of the FOXD4 gene have been associated with several diseases and conditions. A W148R missense mutation in the FOXD4 gene has been linked to a complex phenotype in a three-generation Albanian family, which includes dilated cardiomyopathy (DCM), obsessive-compulsive disorder (OCD), and suicidality. This mutation disrupts a conserved tryptophan residue in the forkhead domain, potentially reducing DNA binding capacity and altering transcriptional activity (Minoretti2007A).

In colorectal cancer (CRC), FOXD4 is highly expressed in cancerous tissues compared to normal tissues, suggesting a poor prognosis. It is considered a potential prognostic biomarker and therapeutic target due to its involvement in pathways like ECM-receptor interaction, which contributes to cancer cell proliferation and invasion (Yuan2020Development; Chen2023FOXD). Higher altered expression of FOXD4 is associated with decreased survival in CRC, with a hazard ratio of 1.788, indicating its potential as a target for inhibitor development in cancer therapy (Rao2022Genomic).

Additionally, FOXD4 is part of a chromosomal duplication involving the 9p24.3-9q21.11 region, which has been associated with symptoms such as mild facial dysmorphism, asociality, decreased school performance, and psychotic behavior in a patient with 9p duplication syndrome (MartínezJacobo2015Clinical).

## Interactions
FOXD4, a transcription factor in the forkhead family, is involved in various interactions with proteins and nucleic acids that influence gene expression during development. In Xenopus embryos, Foxd4l1.1, a homolog of FOXD4, interacts with the protein Xbra. This interaction occurs through the C-terminal of Foxd4l1.1, which binds to Xbra, inhibiting Xbra-induced transcription of the neural repressor ventx1.1. This interaction reduces the binding of Xbra to the ventx1.1 promoter, thereby inhibiting its expression (Kumar2020Foxd4l1.1).

Foxd4l1.1 also interacts with Smad1, a protein involved in BMP signaling. It reduces the C-terminal phosphorylation of Smad1 and increases linker region phosphorylation, leading to the cytoplasmic retention of Smad1. This retention prevents Smad1 from activating ventx1.1 transcription. Foxd4l1.1's interaction with Smad1 affects Smad1's ability to bind DNA, thereby inhibiting the BMP4/Smad1/Ventx1.1 axis (Kumar2020Foxd4l1.1).

These interactions highlight FOXD4's role in modulating transcriptional activity through both direct binding to DNA and interactions with other transcription factors, contributing to the regulation of neural development and ectodermal fate determination in vertebrates (Kumar2020Foxd4l1.1).


## References


[1. (Kumar2020Foxd4l1.1) Shiv Kumar, Zobia Umair, Vijay Kumar, Santosh Kumar, Unjoo Lee, and Jaebong Kim. Foxd4l1.1 negatively regulates transcription of neural repressor ventx1.1 during neuroectoderm formation in xenopus embryos. Scientific Reports, October 2020. URL: http://dx.doi.org/10.1038/s41598-020-73662-4, doi:10.1038/s41598-020-73662-4. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-73662-4)

[2. (Jackson2010Update) Brian C. Jackson, Christopher Carpenter, Daniel W. Nebert, and Vasilis Vasiliou. Update of human and mouse forkhead box (fox) gene families. Human Genomics, June 2010. URL: http://dx.doi.org/10.1186/1479-7364-4-5-345, doi:10.1186/1479-7364-4-5-345. This article has 185 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1479-7364-4-5-345)

[3. (Tokuhiro2017Differential) Shin-ichi Tokuhiro, Miki Tokuoka, Kenji Kobayashi, Atsushi Kubo, Izumi Oda-Ishii, and Yutaka Satou. Differential gene expression along the animal-vegetal axis in the ascidian embryo is maintained by a dual functional protein foxd. PLOS Genetics, 13(5):e1006741, May 2017. URL: http://dx.doi.org/10.1371/journal.pgen.1006741, doi:10.1371/journal.pgen.1006741. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1006741)

[4. (Minoretti2007A) Piercarlo Minoretti, Mariarosa Arra, Enzo Emanuele, Valentina Olivieri, Alessia Aldeghi, Pierluigi Politi, Valentina Martinelli, Sara Pesenti, and Colomba Falcone. A w148r mutation in the human foxd4 gene segregating with dilated cardiomyopathy, obsessive-compulsive disorder, and suicidality. International Journal of Molecular Medicine, March 2007. URL: http://dx.doi.org/10.3892/ijmm.19.3.369, doi:10.3892/ijmm.19.3.369. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijmm.19.3.369)

5. (Chen2023FOXD) FOXD subfamily genes serve as biomarkers and therapy targets in colorectal cancer. This article has 0 citations.

[6. (MartínezJacobo2015Clinical) Lizeth Martínez-Jacobo, Rocío Ortíz-López, Alfredo Rizo-Méndez, Viridiana García-Molina, Sandra K. Santuario-Facio, Fernando Rivas, and Augusto Rojas-Martínez. Clinical and molecular delineation of duplication 9p24.3q21.11 in a patient with psychotic behavior. Gene, 560(1):124–127, April 2015. URL: http://dx.doi.org/10.1016/j.gene.2015.02.010, doi:10.1016/j.gene.2015.02.010. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2015.02.010)

[7. (Yuan2020Development) Yihang Yuan, Ji Chen, Jue Wang, Ming Xu, Yunpeng Zhang, Peng Sun, and Leilei Liang. Development and clinical validation of a novel 4-gene prognostic signature predicting survival in colorectal cancer. Frontiers in Oncology, May 2020. URL: http://dx.doi.org/10.3389/fonc.2020.00595, doi:10.3389/fonc.2020.00595. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2020.00595)

[8. (McMahon2022Loss) Riley McMahon, Tennille Sibbritt, Nadar Aryamanesh, V. Pragathi Masamsetti, and Patrick P. L. Tam. Loss of foxd4 impacts neurulation and cranial neural crest specification during early head development. Frontiers in Cell and Developmental Biology, February 2022. URL: http://dx.doi.org/10.3389/fcell.2021.777652, doi:10.3389/fcell.2021.777652. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2021.777652)

[9. (Rao2022Genomic) Chinthalapally V. Rao, Chao Xu, Yuting Zhang, Adam S. Asch, and Hiroshi Y. Yamada. Genomic instability genes in lung and colon adenocarcinoma indicate organ specificity of transcriptomic impact on copy number alterations. Scientific Reports, July 2022. URL: http://dx.doi.org/10.1038/s41598-022-15692-8, doi:10.1038/s41598-022-15692-8. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-15692-8)